SCM
AMGN icon

SCS Capital Management’s Amgen AMGN Stock Holding History

SCS Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.62M Buy
4,468
+20
+0.4% +$6.85K 0.02% 234
2026
Q1 		$1.57M Sell
4,448
-85
-2% -$30.3K 0.02% 225
2025
Q4 		$1.48M Sell
4,533
-224
-5% -$71.1K 0.02% 241
2025
Q3 		$1.34M Sell
4,757
-671
-12% -$195K 0.01% 256
2025
Q2 		$1.52M Buy
5,428
+12
+0.2% +$3.4K 0.02% 245
2025
Q1 		$1.69M Buy
+5,416
New +$1.6M 0.02% 217

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

SCS Capital Management's AMGN Position: Q2 2026 in Review

SCS Capital Management increased its Amgen (AMGN) stake by 0.45% in Q2 2026, buying an estimated $6.85K and bringing the position to 4,468 shares worth $1.62M. The position accounts for 0.02% of the portfolio, ranked #234.

SCS Capital Management first reported a position in AMGN in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.69M in Q1 2025. 3,143 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • SCS Capital Management held 4,468 shares of Amgen worth $1.62M as of Q2 2026.
  • SCS Capital Management bought 20 Amgen shares in Q2 2026, an estimated $6.85K.
  • Amgen made up 0.02% of SCS Capital Management's portfolio in Q2 2026, its #234 holding.
  • SCS Capital Management first reported a position in Amgen in Q1 2025 and has held it in 6 quarters since.
  • SCS Capital Management's Amgen position peaked at $1.69M in Q1 2025.
  • 3,143 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on SCS Capital Management's 13F filing for Q2 2026, filed 6 Aug 2026.